Marina Publishes Animal Data on Liposomal Delivery System
April 28, 2011
Marina Publishes Animal Data on Liposomal Delivery System
One siRNA formulation resulted in greater than 80 percent knockdown of apolipoprotein B, transthyretin, factor VII, and proprotein convertase subtilisin/kexin type 9 mRNA when administered systemically in a 2 mg/kg dose to animal models.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Marina Defaults on Loan as Bankruptcy Looms
January 31, 2013 / Gene Silencing News - Marina Extends Cash Runway to Year End, Sells Off Equipment
December 13, 2012 / Gene Silencing News - Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina
November 15, 2012 / Gene Silencing News - Marina Says Cash Will Run out at the End of the Month, Reports 2011 Financials
October 18, 2012 / Gene Silencing News - Marina Halts Majority of Operations Under Cash Crunch
June 7, 2012 / Gene Silencing News